The companies, selected following face-to-face interviews with a jury of innovators, entrepreneurs and venture capitalists, will receive a total amount of €94.25 million.
Examples of the projects selected include a 3D printer for food; an innovative treatment for breast cancer; a virtual reality and augmented reality headset capable of human eye resolution; a multi-active cardboard packaging that extends the shelf life of vegetables by 40% and a new type of biodegradable bioplastic. In this phase of the SME Instrument (the so-called Phase 2), each project will receive up to €2.5 million to finance innovation activities such as demonstration, testing, piloting, and scaling up. In addition, the companies will also benefit from 12 days of free business coaching and business acceleration services. Most companies selected for funding are in the field of health, engineering, and information and communication technology (ICT), and are based in Spain (13), the Netherlands (6), followed by France and Finland (both 5), and thirteen other countries across Europe.
The next application deadline for SME Instrument Phase 2 is 14 March 2018.